FDA Commissioner Dr. Marty Makary said Thursday that the United States needs to transform its health care approach from ...

Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed ...

Even the packaged goods industry is getting in on the GLP-1-shift game. Conagra, the North American packaged foods company ...

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...

Covid vaccines from Pfizer and Moderna must carry expanded warning labels informing patients of the risk of rare heart inflammation. The FDA is also cracking down on off-brand GLP-1 drugs. Other ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

A band of clinicians and chronic pain advocates are pushing regulators to scrutinize a controversial risk rating tool.

News last week that a CNN investigative report found dozens of fake podcasts on the popular audio streaming and media service platform Spotify, illegally ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.